Report highlights 20 women reshaping biopharma across oncology and rare disease fields

The 2026 special report spotlights twenty women who are driving change in biopharma, covering areas such as oncology and rare diseases.

The series, now in its eighth year, has recognized over 160 women across the industry, and the editors say they have identified recurring themes in the career paths of these leaders.

Readers can access the full profiles by signing up for a free account, which also offers limited free articles and newsletter options.